UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
November 3, 2005
Commission File Number 001-11145
BIOVAIL CORPORATION
(Translation of Registrants name into English)
7150 Mississauga Road, Mississauga, Ontario, CANADA, L5N 8M5
(Address of principal executive office and zip code)
Registrants telephone number, including area code: (905) 286-3000
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ý Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1).
Yes o No ý
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7).
Yes o No ý
Indicate by check mark whether by furnishing the information contained in this form the registrant is also hereby furnishing the information to the Commission pursuant to Rule 12g 3-2(b) under the Securities Exchange Act of 1934.
Yes o No ý
BIOVAIL CORPORATION
This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the registration statement on Form S-8 (Registration No. 333-92229) of Biovail Corporation.
INDEX
Exhibit 99.1 Press Release Biovail Enters Into Commercial Alliance for Tramadol Products
Exhibit 99.2 Presentation Biovail Enters Into Agreement with Ortho-McNeil for Tramadol Products
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
Biovail Corporation |
|
|
|
|
|
|
|
|
|
Date: |
November 3, 2005 |
By: |
/s/ JOHN R. MISZUK |
|
|
|
John R. Miszuk |
|
|
|
Vice President, Controller and |
|
|
|
Assistant Secretary |
2